The authors have received research support from Abbvie Pharmaceuticals (ADP), Alcon Research, LLC (ADP), Bausch + Lomb (ADP), and Topcon (ADP). The authors have served as consultants for Abbvie (KSA), Alcon (KSA), Bausch + Lomb (ADP, KSA), BRIM (ADP), Dompe (KSA), HanAll Biopharma (ADP), Harrow (KSA), Mintra Health (ADP), Lexitas Pharma Services (ADP), Orasis Pharmaceuticals (ADP), and Tarsus (KSA). Dr. Pucker is the owner of Eminent Ophthalmic Services, LLC, and he is an employee of Mintra